PURPOSE: The Surgical Apgar Score (SAS) is a simple tally based on intra-operative heart rate, blood pressure and blood loss; it predicts 30-day major postoperative complications and mortality in different surgical fields, but no validation has been performed in general orthopaedic surgery. METHODS: A prospective assessment of the SAS in 723 consecutive patients undergoing major and intermediate orthopaedic procedures was performed in an 18-month period. The SAS was calculated immediately after surgery, and the occurrence of major complications or death was registered within a 30-day follow-up. RESULTS: Thirty-seven patients had ≥1 complication (5.12 %). The complication rate did not augment as the score decreased (SAS 9-10 = 6.56 %; SAS 7-8 = 2.62 %; SAS 5-6 = 7.21 %; SAS ≤4 = 10.2 %), the relative risk did not augment as the score decreased and the likelihood ratio did not increase with decreasing SAS values, except in the subgroup of patients undergoing spine surgery. The C-statistic was 0.59 (95 % confidence interval 0.48-0.69), a weak discriminatory value. Using a threshold of 7 to define high-risk and low-risk patients, the SAS allowed risk stratification only for spine surgery. CONCLUSIONS: The SAS does not predict 30-day major complications and death in patients undergoing general orthopaedic surgery, but it is useful in the subgroup of patients undergoing spine surgery.
PURPOSE: The Surgical Apgar Score (SAS) is a simple tally based on intra-operative heart rate, blood pressure and blood loss; it predicts 30-day major postoperative complications and mortality in different surgical fields, but no validation has been performed in general orthopaedic surgery. METHODS: A prospective assessment of the SAS in 723 consecutive patients undergoing major and intermediate orthopaedic procedures was performed in an 18-month period. The SAS was calculated immediately after surgery, and the occurrence of major complications or death was registered within a 30-day follow-up. RESULTS: Thirty-seven patients had ≥1 complication (5.12 %). The complication rate did not augment as the score decreased (SAS 9-10 = 6.56 %; SAS 7-8 = 2.62 %; SAS 5-6 = 7.21 %; SAS ≤4 = 10.2 %), the relative risk did not augment as the score decreased and the likelihood ratio did not increase with decreasing SAS values, except in the subgroup of patients undergoing spine surgery. The C-statistic was 0.59 (95 % confidence interval 0.48-0.69), a weak discriminatory value. Using a threshold of 7 to define high-risk and low-risk patients, the SAS allowed risk stratification only for spine surgery. CONCLUSIONS: The SAS does not predict 30-day major complications and death in patients undergoing general orthopaedic surgery, but it is useful in the subgroup of patients undergoing spine surgery.
Authors: Atul A Gawande; Mary R Kwaan; Scott E Regenbogen; Stuart A Lipsitz; Michael J Zinner Journal: J Am Coll Surg Date: 2006-12-27 Impact factor: 6.113
Authors: Sandip M Prasad; Marcos Ferreria; Alexander M Berry; Stuart R Lipsitz; Jerome P Richie; Atul A Gawande; Jim C Hu Journal: J Urol Date: 2009-01-15 Impact factor: 7.450
Authors: Thomas H Wuerz; Scott E Regenbogen; Jesse M Ehrenfeld; Henrik Malchau; Harry E Rubash; Atul A Gawande; David M Kent Journal: Clin Orthop Relat Res Date: 2010-12-04 Impact factor: 4.176
Authors: Israel Zighelboim; Nora Kizer; Nicholas P Taylor; Ashley S Case; Feng Gao; Premal H Thaker; Janet S Rader; L Stewart Massad; David G Mutch; Matthew A Powell Journal: Gynecol Oncol Date: 2009-12-16 Impact factor: 5.482
Authors: Scott E Regenbogen; Jesse M Ehrenfeld; Stuart R Lipsitz; Caprice C Greenberg; Matthew M Hutter; Atul A Gawande Journal: Arch Surg Date: 2009-01